Related Experiment Video
Updated: Jun 19, 2026
11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Cutaneous and mucocutaneous leishmaniasis
1Divisions of Dermatology and Adult Infectious Disease, Department of Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Dermatologic Therapy
|November 6, 2009
Summary
Leishmaniasis, a parasitic disease, presents varied skin and mucosal symptoms. Early diagnosis and species-specific treatment are crucial for managing cutaneous and mucocutaneous leishmaniasis, preventing disfigurement and economic impact.
Area of Science:
- Medical Parasitology
- Infectious Diseases
- Dermatology
Background:
- Leishmaniasis encompasses diseases caused by Leishmania parasites, with cutaneous and mucocutaneous forms being the focus.
- Clinical presentation varies widely, influenced by host and parasite factors, ranging from asymptomatic cases to severe ulcerations.
- Skin ulcerations, regardless of treatment or spontaneous resolution, often lead to disfiguring scars with significant psychosocial and economic consequences.
Purpose of the Study:
- To review the diagnostic approaches for cutaneous and mucocutaneous leishmaniasis.
- To outline current treatment strategies for these forms of leishmaniasis.
- To emphasize the importance of healthcare provider education in recognizing and managing leishmaniasis globally.
Main Methods:
- Literature review focusing on diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis.
- Analysis of factors influencing disease manifestation and patient outcomes.
- Synthesis of information on diagnostic tests and therapeutic options based on Leishmania species and disease severity.
Main Results:
- Diagnostic confirmation requires testing in patients with compatible symptoms and a history of travel to endemic areas.
- Treatment decisions are guided by the specific Leishmania species and the risk of severe or disfiguring disease.
- Effective management strategies are essential to mitigate the long-term impact of leishmaniasis.
Conclusions:
- Accurate diagnosis and tailored treatment are vital for managing cutaneous and mucocutaneous leishmaniasis.
- The increasing global prevalence necessitates enhanced awareness and education among healthcare professionals worldwide.
- Prompt recognition and appropriate intervention can reduce the morbidity and socioeconomic burden associated with leishmaniasis.
Related Concept Videos
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:23Skin Diseases and Disorders
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.